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QT were madefrom three individual QRS complexes and from an averaged
QRST complex derived from the full 15 second recording. QTd was deter-
mined aa the maximum minus the minimum QT value for juat the 6 chest
Ieedaas well aa for all 12 leads.
Results: QTd’s from each group were mmpersd from the single beats
and the averaged aignals as shown below. Values are in ms + standard
deviation. l = p e 0.05 vs single beat VT patient QTd and va averaged Ml
patient QTd.
& double sensing of the atrfal electrogram, was demonstrated in the. DAP
mode in 7 of 13 pts. Reprogramming sansing to single site (CSOS)pacing
did not eliminate OV. Corrchsions: The prevalence of OV & inappropriate
mode switches in DAP & CSOSpacing is higher than previously reported. 2)
Diagnostics are useful in identifying possible OV, but a clinic visit is required
for definitive identification. 3) Continuous atrial pacing is achieved in most
pts, & device data are valuable in achieving this objective.
Chestleads All 12 leads
Singlebeats Averaged Singlebeats Averaged
Ml patients 37• 19 3a* 22 53• 21 53& 25
VT patients 37* 17 48 & 29* 52& 18 56+ 32”
Corrc/usions:QTdispersion isabetferdiscriminator between patients with
and without VT when measured from averaged signals than from individual
beata. This ia likely due to decreased noise from the averaging process
allowing more accurate measurement of the QT values.
D956166 QTDispersionsndVentricularArrhythmiasinPstisntswithProgressiveMusculerDystrophyof
the DuchenneType
M. Yotsukura, Y.Tomono, T. Yamaguchi, M. Taya, J. Suzuki, T. Tamura,
T. Ishihara, K. Ishikawa. Kyorin University Tokyo,Japan
A high QT dispersion is said to be a risk factor for sudden death due to
arrhythmia in patients with myocsrdial infarction and cardiomyopathy. Pro-
gressive muscular dystrophy of the Duchenne type (DMD) is associated with
myocardial lesions, and ventricular arrfryfhmias oftan occur in patients with
this disease. However,,there have been no repoffs of QT dispersion in DMD.
We then comperad QT diapecsionwith the severity of skeletal muscle dam-
age according to the Swinyard-Deaver 8-stage and ventricular arrhythmias.
Standard 12-lead ECGa (paper speed: 50 mrrdsec) and Helter ECGSwere
recorded slmultaneoudy in every subjact. We measured QTc in every lead
of the standard ECG and defined “QT dispersion” as the difference between
the maximum and minimum values among the 12 leads. QT dispersion in the
DMD patients (n =52) averaged 69 +25 msec. The QT dispersion valua was
83+ 20 msec in stage 5 (n = 11), 80 +22 msec in stage 6 (n = 12), 73 +
24 msec in stage 7 (n = 13), and 77 + 30 maec in atege 8 (n = 16). Thus,
QT dispersion tendad to increase as the stage of skeletal muscle damage
increased. Malignant ventricular arrhythmias of Lown’s grade ?111wera ob-
sarvad in 3 (10.7%) out of the26 patiantawith QT dispersion <70 msec and in
9(37.5%) out of the24 patients with QT dispersion ?70 msec. The incidence
of malignant ventricular arrhythmias was significantly higher in patients with
QT diapersion 270 maec than in those with QT dispersion <70 msec (p <
0.05). QT dispersion is a risk factor for malignant ventricular arrhythmias in
DMD, and especially, QTdispereion ?70 msac is highly associated with high
incidence of malignant ventricular arrhythmias.
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P.Delfaut, A. Prakash, C. Lewis, A. Munsif, R. Krol, S. Saksena. Eastern
Heart Institute, Passaic, NJ, USA
We compared a device-based analysis with clinical& ECG followup in order
to estimate the utility of stored diagnostic data obtained with a novel pacing
system inpatients [pte]with atriai fibrillation IAF1.Thirtaen AFpts had2 bipolar
atrial leads placed in the high RA & coronary sinus ostium ICSOS]connected
to a Madtronic 7840 pacemaker for continuous atrial pacing. Dual site atrial
pacing IOAP]uaedthe CSoaascethode &high RAasancde. High rate eventa
[HRE], defined as atrial rate =- 175 bpm, were classified as sustained (?30
s) or nonsustained (< 30 s). Results: Mean % atrial pacing at initial followup
(S 1 f710)was77 + 29% & increased to 86 + 24% at last followup (mean 7
& 4 mos) after reprogramming or adjuvant drug therapy. HRE detected on
the atrial channel at 0.5 mV sensitivity occurred in all pts & resulted in 3 to >
255 mode switching episodea. Documented AF recurrences occurred in only
4 pts (maan 1.5/pt). Device interrogation revealed beat-to-beat fluctuation in
HRE ranging from 90 to 300 bpm in 6 of 10 pts (60%) with a nonsustained to
sustained HRE ratio of 0.S.Oversensing of evants IOV], both far field R wave
1957-1741 AtrialArrhythmiaDetechon-initial Experience
with a SubcutaneousElactrodeArray
P.Fotuhi, C. Condie, H, Bondke, W. Combs, H. Theres, K. Stangl,
G. Baumann. I Medical Clinic, Charite’, Berlin, Germany, Medfronic,
Minneapolis, MN, USA
Background: Atrial arrhythmia (AA) discrimination remains a significant
technological challenge for permanently implanted devices e.g. atrial and
vantriculer defibrillator and pacemakers. Examination of surface ECG’S is
a standard means of discriminating sinus rhythm end atrial fibrillatiordflutter.
We examined the feasibility of detecting and discrimination of AA by a far
field ECG (FFECG).
Methods: Surface ECG and FFECG (from the pacemfrker pocket) ware
recordad in 16 patients (61.4 + 11.3 years) with AA undergoing standard
pecemakar implant (10) or replacement (6). The FFECG waa recordad with
a pacemaker sized 4 electrode array acutely placed in the pacemaker pocket
during implantation. The signals were analyzsd to obtain Peak to peak R-
wave amplituda on each channal. An automatic detection algorithm was
tested on tha FFECG to determine if R to R interval variability (indicative of
AA) can be detected using the FFECG.
Resu/fs: R wavea were visually discernible in all patient recordings. The
percent oversensing and undarsansing of automatic R wave detection on the
FFECG was 3% and 9%, respectively. R to R variability analysis using the
FFECG produced results similar to those using the surface ECG.
Peak to peak R-wave amplitude are summarized in the table.
n=16 FFECG 1 FFECG 2 surface
Mean (mV) 0,1513 0,0805 1.40s5
Std & 0.1826 * 0.0915 * 0.4573
Conclusion: Our initial experience showed the feasibility and reliability of
atrial arrhythmia detection with a subcutaneous elactrcde array. This system
may offer a helpful adjunct to implantable devices arrhythmia detection and
rhyihm classification.
ml flowShouldAtrial sSnSitivit’y~ePrOgammed FOr
OptimalAutomaticModeSwitching?
S.-K. Leung 1, C.-P. Leu, C. Lam 1, H.-F.Tse, F.Chung, M.-O. Tang,
G. Ayres. 1Kwong Wah Hospital& Quaen Mary Hospital, Hong Kong
Although Automatic Mode Switching (AMS) can avoid tracking of atrial fibril-
lation (AF) in a DDDR pacemaker, the response of the AMS in dual chamber
pacers rely on corract detection of AF which can be affacted by the prc-
grammad atrial sensitivity (AS). Atrial elactrogram amplitude (AEGM) are
different in sinus rhythm and during AF, and the optimal AS for AMS has
not been studied. Bipolar AEGM during 780 episodas of sinus rhythm and
AF recorded on taps from 15 patients with AF were replayed into 3 dual
chamber rate adaptive pacemakers with AMS algorithms. (TheraDR 7940,
Medtronic Inc., Marathon 294-09, tntermadics Inc. and MetaDDDR 1254
Teletronic Inc.). The lower and upper rates were programmed to of 50 and
150 bpm with a TARP at 410 ms AMS rate at 175 bpm, Af14Scounts to 5 in
Marathonand MetaDDDR The AS was randomly programmed to the highest
available AS, nominal AS, at half of the measured AEGM in sinua rhythm to
assess AMS during AF; and half of the AS half of the mean AEGM in AF to
assess overeensing during sinus rhythm. Ineffective AMS was defined when
ventricular pacing occurred at ?102 bpm 21/3 of time during AMS response
toAF. The results (tabla) were expressed asa parentage of the total number
of tests. ‘ P <0.05 by Chi Square.
AtrialSensitive Failure Ineffective Intermittent Oversense Undersenaeof AF
(mV) of AfvfS AMS track AF of noise Episodes Duration(s)
High 0.35 0“/0” 3“/.” 17”/4” 57”/0” 6“/0: 2,2 + 1,6*
Nominal 0.77 OO/.” 13”/.” 270/. 340/n* 19”/o* 8.3 & 2.8*
Half PWA 2.1 94/0’ 36”/o* 50”/0” lo%” 36”A* 47 * 9*
Half AF 1.5 O“A” 26”/-” 48%” 20%” 17”A* 7 + 3,5”
Cone/usion.’TheAMS function of the existing pacemaker was significantly
limited by the programmed AS. New algorithms such as auto-adjustment of
atrial sensitivity according to P wave amplitude may be useful to optimise AF
sensing without oversensing in SR.
